Ipsen and BioLabs Hôtel-Dieu invite you to apply for Ipsen’s second Golden Ticket following the inaugural Golden Ticket awarded in 2023. This Golden Ticket provides the winning applicant, dedicated lab bench and office space for one year at BioLabs Hôtel-Dieu, and access to the Ipsen team of scientific and industry advisors.
Application Process
The official application process can be found below. Please read and verify your availability before submitting your application.
Golden Ticket Benefits
Eligibility Snapshot
Companies working on research and development in the fields of:
Innovative therapeutic approaches in
Oncology
Therapeutic approaches with a biomarker strategy for hematology or solid tumors in small patient segments
Neuroscience
Therapeutic approaches for movement disorders, neuroinflammation, neurodegeneration (rare diseases or small patient segments)
Rare Disease
Therapeutic approaches for rare liver, gastro-intestinal, skeletal, neuromuscular diseases as well as rare diseases within endocrinology, metabolism, hematology, autoimmunity
Innovative technology platforms, including
Drug Discovery
Drug Targeted Delivery
Biomarket Discovery
The Application Process
01
Submit the online application by April 30, 2024
02
A subset of applications will be identified as finalist by the contest judges by
June 17, 2024
03
Finalists will present their company & scientific concept at an in-person event on
June 27, 2024
04
One award will be granted
Good luck!
Judging Criteria and Judges
The Committees will judge all Applications based on the following criteria:
Quality of the science and scientific rationale: description of the scientific rationale and of the unique technical features of the proposed solution, summary of proof-of-concept data
Unmet need and differentiation of the proposed approach: (i) description of the problem/unmet need that the technology addresses and of the adequation of the proposed solution to the unmet need and (ii) description of the differentiation of the proposed solution within the international competitive landscape
Execution capabilities of the Participant’s team: biographies of the founders, description of the composition of the Participant’s team, description of a road map for the project
Sustainability and impact of the Participant’s activities on the environment and society
Motivation for coming to BioLabs Hôtel Dieu
-
What is the AbbVie Golden Ticket – BioLabs Award?Golden Tickets are vouchers that AbbVie can award to a startup company of their choice and provide that company with one lab bench in BioLabs Heidelberg or Paris for one year. The value of a Golden Ticket prepays the cost of one (1) single bench, one (1) single desk and Biolabs membership for one person for one (1) year. The value of a single bench may be applied towards fees for a private lab in Biolabs Heidelberg or Paris pending availability at the time of their desired start. The Golden Ticket winner must pay the difference between the larger space and the value of the single bench covered by their Golden Ticket. If there are no benches available, the value of the golden ticket will be extended while the company remains on the waitlist for a bench. The winner will receive priority admission or renewal for one year’s use of a lab bench and access to all shared facilities at Biolabs Heidelberg or Paris, and opportunities to engage with AbbVie scientific and business executives.
-
How do I know if I am eligible for a Golden Ticket?Golden Tickets may be awarded to either startup companies that are interested in joining the Biolabs community or current Resident Companies. To be eligible to participate to have the opportunity to receive the Award, the Applicant must: (1) be an independent entity (SME), either currently formed under the laws of Germany; (2) not have raised more than $7.5 million United States dollars in capital or have trailing twelve month revenue of more than $3 million United States dollars as of the time of Application and the closing date for the Contest; 3) submit a complete Application; (4) represent and warrant that the Applicant has read and agrees to abide by all requirements of these Rules; (5) not be affiliated with or employed by AbbVie or Biolabs including as an employee, contractor, officer or director of AbbVie or Biolabs and including as an immediate family member of AbbVie or Biolabs (including parents, spouses, children, siblings or any individual residing in the household of a AbbVie, officer or director (whether or not related)); and (6) not be an academic institution such as a college, university or school. Diagnostics, Devices, Research Tools, and Healthcare-Services & IT companies are excluded.
-
When will I be able to use my Golden Ticket?The top proposals will be invited for a virtual pitch presentation on November 13 or November 14, 2024. The selected winner must be financially and scientifically ready to move into Biolabs Heidelberg or Paris within three months of receiving the ticket and to execute the submitted research plan.
-
Where can I find more details on AbbVie’s areas of focus for external innovation?Please refer to our Corporate Strategy Organization’s brochure: https://www.abbvie.com/partnerships/areas-of-interest.html
Contact Us
If you have any questions about, BioLabs Hôtel-Dieu or this Golden Ticket, contact
If you have any questions about BioLabs, contact
